Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?
Authors
Keywords
Liver transplantation, Antiviral therapy, Hepatitis C virus, Protease inhibitor therapy, Adverse events, Bilirubin, Fibrosis, Thrombocytopenia
Journal
PLoS One
Volume 10, Issue 9, Pages e0138091
Publisher
Public Library of Science (PLoS)
Online
2015-09-23
DOI
10.1371/journal.pone.0138091
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sofosbuvir and Ribavirin for Treatment of Compensated Recurrent Hepatitis C Virus Infection After Liver Transplantation
- (2015) Michael Charlton et al. GASTROENTEROLOGY
- Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
- (2015) Michael Charlton et al. GASTROENTEROLOGY
- A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy
- (2014) James R. Burton et al. JOURNAL OF HEPATOLOGY
- Optimal therapy in hepatitis C virus liver transplant patients with direct acting antivirals
- (2014) Audrey Coilly et al. LIVER INTERNATIONAL
- An Interferon-free Antiviral Regimen for HCV after Liver Transplantation
- (2014) Paul Y. Kwo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of Recurrent Genotype 1 Hepatitis C Post-Liver Transplantation: Single Center Experience with Telaprevir-Based Triple Therapy
- (2014) C. Werner et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
- Eltrombopag Increases Platelet Numbers in Thrombocytopenic Patients With HCV Infection and Cirrhosis, Allowing for Effective Antiviral Therapy
- (2013) Nezam H. Afdhal et al. GASTROENTEROLOGY
- Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir
- (2013) Stefan Mauss et al. HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
- (2013) JOURNAL OF HEPATOLOGY
- Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: A multicenter experience
- (2013) Audrey Coilly et al. JOURNAL OF HEPATOLOGY
- Management of HCV transplant patients with triple therapy
- (2013) Audrey Coilly et al. LIVER INTERNATIONAL
- HCV direct-acting antiviral agents: the best interferon-free combinations
- (2013) Raymond Schinazi et al. LIVER INTERNATIONAL
- Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation
- (2013) Surakit Pungpapong et al. LIVER TRANSPLANTATION
- Drug–drug interactions during antiviral therapy for chronic hepatitis C
- (2013) Jennifer J. Kiser et al. Nature Reviews Gastroenterology & Hepatology
- Practical Management of Boceprevir and Immunosuppressive Therapy in Liver Transplant Recipients with Hepatitis C Virus Recurrence
- (2012) Audrey Coilly et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Maximizing Opportunities and Avoiding Mistakes in Triple Therapy for Hepatitis C Virus
- (2012) A. Sidney Barritt et al. GASTROENTEROLOGY
- Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers
- (2012) Ellen Hulskotte et al. HEPATOLOGY
- A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation
- (2012) Gregory T. Everson et al. HEPATOLOGY
- 1419 A RANDOMIZED TRIAL COMPARING RIBAVIRIN DOSE REDUCTION VERSUS ERYTHROPOIETIN FOR ANEMIA MANAGEMENT IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC HEPATITIS C RECEIVING BOCEPREVIR PLUS PEGINTERFERON/RIBAVIRIN
- (2012) F.F. Poordad et al. JOURNAL OF HEPATOLOGY
- Liver transplantation for HBV-related cirrhosis in Europe: An ELTR study on evolution and outcomes
- (2012) Patrizia Burra et al. JOURNAL OF HEPATOLOGY
- Protease inhibitor-based triple therapy in chronic hepatitis C: guidelines by the French Association for the Study of the Liver
- (2012) Vincent Leroy et al. LIVER INTERNATIONAL
- Interleukin-28B polymorphism in hepatitis C and liver transplantation
- (2012) Andres Duarte-Rojo et al. LIVER TRANSPLANTATION
- Fibrosing Cholestatic Hepatitis in HIV/HCV Co-Infected Transplant Patients-Usefulness of Early Markers After Liver Transplantation
- (2011) T. M. Antonini et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus
- (2011) Varun Garg et al. HEPATOLOGY
- Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin
- (2008) Marina Berenguer JOURNAL OF HEPATOLOGY
- Hepatitis C virus therapy in liver transplant recipients: Response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis
- (2008) Bruno Roche et al. LIVER TRANSPLANTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started